STAT3 and ovarian carcinoma: Enhances chemosensitivity in ovarian cancer cells by inhibiting STAT3 signaling; reduces tumor-promoting macrophage interactions with cancer cells; synergistic with chemotherapy agents like paclitaxel and cisplatin.